Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KO CocaCola	$81.97 -0.2%	$81.31	$65.35 ▼ $85.68	$352.67B	0.34	17.42 million shs	12.94 million shs
O Realty Income	$64.96 -0.3%	$62.19	$55.86 ▼ $67.93	$60.57B	0.72	6.20 million shs	3.89 million shs
PFE Pfizer	$24.91 +0.6%	$25.19	$23.11 ▼ $28.75	$141.97B	0.35	42.55 million shs	27.25 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KO CocaCola	+0.69%	-2.59%	+3.32%	+9.73%	+17.44%
O Realty Income	-0.87%	+1.60%	+7.92%	+1.61%	+15.33%
PFE Pfizer	-1.33%	+1.17%	-2.01%	-9.40%	+1.17%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KO CocaCola	$81.97 -0.2%	$81.31	$65.35 ▼ $85.68	$352.67B	0.34	17.42 million shs	12.94 million shs
O Realty Income	$64.96 -0.3%	$62.19	$55.86 ▼ $67.93	$60.57B	0.72	6.20 million shs	3.89 million shs
PFE Pfizer	$24.91 +0.6%	$25.19	$23.11 ▼ $28.75	$141.97B	0.35	42.55 million shs	27.25 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KO CocaCola	+0.69%	-2.59%	+3.32%	+9.73%	+17.44%
O Realty Income	-0.87%	+1.60%	+7.92%	+1.61%	+15.33%
PFE Pfizer	-1.33%	+1.17%	-2.01%	-9.40%	+1.17%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KO CocaCola	2.93	Moderate Buy	$89.33	8.99% Upside
O Realty Income	2.47	Hold	$67.17	3.41% Upside
PFE Pfizer	2.19	Hold	$28.50	14.41% Upside

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/21/2026	KO CocaCola	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$89.00 ➝ $91.00
7/16/2026	KO CocaCola	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$92.00 ➝ $98.00
7/15/2026	O Realty Income	Huntington Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$70.00
7/15/2026	O Realty Income	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$64.00 ➝ $65.00
7/14/2026	KO CocaCola	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$91.00 ➝ $97.00
7/13/2026	PFE Pfizer	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$34.00 ➝ $30.00
7/13/2026	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$36.00 ➝ $35.00
7/10/2026	KO CocaCola	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$85.00 ➝ $90.00
7/10/2026	KO CocaCola	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$90.00 ➝ $95.00
7/10/2026	PFE Pfizer	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$27.00 ➝ $26.00
7/9/2026	KO CocaCola	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$83.00

(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KO CocaCola	$47.94B	7.36	$3.27 per share	25.03	$7.97 per share	10.28
O Realty Income	$5.88B	10.30	$3.92 per share	16.56	$43.62 per share	1.49
PFE Pfizer	$62.58B	2.27	$4.37 per share	5.70	$15.26 per share	1.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KO CocaCola	$13.11B	$3.18	25.78	23.55	3.26	27.80%	40.55%	12.90%	7/28/2026 (Estimated)
O Realty Income	$1.06B	$1.22	53.24	14.12	5.13	18.94%	2.80%	1.55%	8/5/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	19.02	8.74	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)

Latest KO, O, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	O Realty Income	$0.3977	N/A	N/A	N/A	$1.40 billion	N/A
8/4/2026	Q2 2026	PFE Pfizer	$0.68	N/A	N/A	N/A	$14.42 billion	N/A
7/28/2026	Q2 2026	KO CocaCola	$0.92	N/A	N/A	N/A	$13.17 billion	N/A
5/6/2026	Q1 2026	O Realty Income	$1.10	$1.13	+$0.03	$0.33	$1.39 billion	$1.55 billion
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/28/2026	Q1 2026	KO CocaCola	$0.8120	$0.86	+$0.0480	$0.91	$12.24 billion	$12.47 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
KO CocaCola	$2.12	2.59%	+4.46%	66.67%	64 Years
O Realty Income	$3.25	5.00%	+4.50%	266.39%	31 Years
PFE Pfizer	$1.72	6.90%	-13.20%	131.30%	16 Years

Latest KO, O, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/15/2026	KO CocaCola	quarterly	$0.53	2.57%	9/15/2026	9/15/2026	10/1/2026
6/24/2026	PFE Pfizer	quarterly	$0.43	7.15%	7/24/2026	7/24/2026	9/1/2026
7/7/2026	O Realty Income	monthly	$0.2710	5.08%	7/31/2026	7/31/2026	8/14/2026
6/9/2026	O Realty Income	monthly	$0.2710	5.25%	6/30/2026	6/30/2026	7/15/2026
4/30/2026	KO CocaCola	quarterly	$0.53	2.62%	6/15/2026	6/15/2026	7/1/2026
5/14/2026	O Realty Income	monthly	$0.2705	5.29%	5/29/2026	5/29/2026	6/15/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KO CocaCola	1.09	1.36	1.15
O Realty Income	0.72	1.56	1.56
PFE Pfizer	0.67	1.25	0.94

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KO CocaCola	70.26%
O Realty Income	70.81%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
KO CocaCola	0.90%
O Realty Income	0.10%
PFE Pfizer	0.62%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KO CocaCola	65,900	4.30 billion	4.26 billion	Optionable
O Realty Income	400	932.49 million	931.56 million	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable

KO, O, and PFE Headlines

Recent News About These Companies

What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season

4 hours ago | finance.yahoo.com

Why CELC Stock Declined 15% in a Week Despite a Major FDA Win

4 hours ago | finance.yahoo.com

What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season

July 21 at 11:06 AM | zacks.com

Parallel Advisors LLC Has $3.63 Million Stock Holdings in Pfizer Inc. $PFE

July 21 at 5:36 AM | marketbeat.com

Commerzbank Aktiengesellschaft FI Has $12.48 Million Stock Holdings in Pfizer Inc. $PFE

July 21 at 4:07 AM | marketbeat.com

Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know

July 20 at 6:46 PM | zacks.com

Pfizer (NYSE:PFE) Stock Price Down 1.2% - Time to Sell?

July 20 at 5:20 PM | marketbeat.com

July 20 at 1:28 PM | finance.yahoo.com

1 Stock Under $50 to Target This Week and 2 We Question

July 20 at 1:28 PM | finance.yahoo.com

Pfizer (PFE) Faces New International Patent Lawsuits Over Covid 19 Vaccine

July 20 at 1:28 PM | finance.yahoo.com

July 20 at 10:01 AM | zacks.com

Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?

July 20 at 8:26 AM | fool.com

Sound Shore Management Inc. CT Takes Position in Pfizer Inc. $PFE

July 20 at 5:59 AM | marketbeat.com

Pfizer Inc. $PFE Shares Sold by KBC Group NV

July 20 at 5:36 AM | marketbeat.com

SEB Asset Management AB Makes New $37.41 Million Investment in Pfizer Inc. $PFE

July 20 at 5:28 AM | marketbeat.com

Independent Financial Group LLC Takes $1.80 Million Position in Pfizer Inc. $PFE

July 20 at 5:03 AM | marketbeat.com

Dimensional Fund Advisors LP Raises Stake in Pfizer Inc. $PFE

July 20 at 4:08 AM | marketbeat.com

Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?

July 20 at 3:50 AM | fool.com

Allen Holding Inc. NY Purchases 480,200 Shares of Pfizer Inc. $PFE

July 20 at 3:19 AM | marketbeat.com

Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now

July 19 at 7:51 AM | fool.com

Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now

July 19 at 7:15 AM | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

$81.97 -0.15 (-0.19%)

Closing price 03:59 PM Eastern

Extended Trading

$82.00 +0.03 (+0.03%)

As of 07:01 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Realty Income NYSE:O

$64.96 -0.22 (-0.34%)

Closing price 03:59 PM Eastern

Extended Trading

$65.00 +0.05 (+0.08%)

As of 07:00 PM Eastern

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).

Pfizer NYSE:PFE

$24.91 +0.16 (+0.65%)

Closing price 03:59 PM Eastern

Extended Trading

$24.92 +0.02 (+0.06%)

As of 07:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KO, O, and PFE Earnings

Compare Dividends

Latest KO, O, and PFE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KO, O, and PFE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

Realty Income NYSE:O

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KO, O, and PFE Earnings

Compare Dividends

Latest KO, O, and PFE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KO, O, and PFE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

Realty Income NYSE:O

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools